EVA1A: A Novel Target for Metabolic Dysfunction-Associated Steatotic Liver Disease Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a growing global health concern …
Tag:
Steatosis
-
-
GLP-1 Receptor Agonists: A New Era in Metabolic and Cardiovascular Health A sweeping review published in The Lancet reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, …